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Context: Symptomatic uterine fibroids are frequently encountered in gynecological practice in black populations. An evaluation 
of the surgical management is in order to audit practice, highlight complications, and facilitate care.
Aims: This study aimed to evaluate morbidity following abdominal myomectomy and hysterectomy for symptomatic uterine 
fibroids.
Settings and Design: A cross‑sectional study retrospectively reviewing cases of symptomatic uterine fibroids that were 
managed surgically at a tertiary hospital in south‑west Nigeria.
Methods and Material: Surgeries performed over a five‑year period were retrieved from the gynecological theatre of the 
hospital. The case notes were retrieved and information on socio‑demographic, perioperative and postoperative characteristics 
was obtained.
Statistical analysis used: Chi‑square tests and Student’s‑t tests were performed to evaluate categorical and continuous 
variables, respectively. Significant P was set at < 0.05.
Results: Of 214 eligible cases, 79 (36.9%) had hysterectomy and 135 (63.1%) had myomectomy. No other surgical treatment 
methods were employed. Age was the only significant socio‑demographic feature; younger women were more likely to have 
myomectomy (P < 0.001). Mean blood loss and transfusion rates were comparable between the two groups. Complications 
included hemorrhage in 36.0%, wound infection in 4.7%, and postoperative fever in 1.9%. There were no conversions of 
myomectomy to hysterectomy and no mortalities. There was no significant difference in the prevalence of complications in 
either surgery group.
Conclusions: Apart from hemorrhage, morbidities were few in this series. Gynecologists should ensure adequate preparations 
to control blood loss before and during fibroid surgery.
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Introduction
Uterine fibroids are benign tumors of the uterus composed 
of smooth muscle and connective tissue.[1] These tumors are 
the most common uterine neoplasm with incidence rates 
of 30%–40% in women above 40 years of age.[2] They can 
enlarge the uterus significantly and predispose to ureteric 
compression, urinary retention, constipation, and tenesmus.[3]
In retrospective studies from Nigeria, symptoms from 
uterine fibroids were present in 9.8%–13.6% of all gynecological 
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admissions.[4,5] They can increase uterine size as much as 
36 weeks; however, most were between 13 and 16-week 
size at presentation.[6]
Abdominal myomectomy and hysterectomy are frequently 
performed for fibroids. In the Nigerian study, 9.3% of all 
cases over 25 years period were managed surgically[6]; rates 
for abdominal hysterectomy and myomectomy were as high 
as 70.4% and 86% respectively.[7]
Though newer modalities for nonsurgical or noninvasive 
modes of management are now available,[8] the use of uterine 
artery embolization, temporary transvaginal occlusion 
of the uterine arteries, fibroid myolysis, and magnetic 
resonance-focused ultrasound surgery are not yet widespread 
in Nigeria. Conventional myomectomy and hysterectomy 
remain prominent on operation lists. Surgery may be followed 
by injuries to contiguous organs such as the bladder, ureters, 
and bowel, hemorrhage with severe anemia, infections, 
pyrexia, and fistula formation.[9,10]
Symptomatic uterine leiomyomas are frequently encountered 
in gynecology, therefore, there is a need to evaluate their 
surgical management in order to audit practice and identify 
areas that require further research and clinical trials. This 
study aimed to identify complications or morbidities 
following abdominal myomectomy and hysterectomy for 
symptomatic uterine fibroids.
Subjects and Methods
This was a retrospective study of hospital records over a 
5-year period at a tertiary hospital in south-west Nigeria. 
During this period, 2,888 patients were admitted to 
the hospital’s gynecology wards. Five hundred and fifty 
patients had a clinical diagnosis of uterine fibroids. Surgical 
treatment with abdominal myomectomy or hysterectomy was 
performed in 261 cases (47.5%). We excluded cases without 
histological evidence of leiomyomata and cases that included 
evidence of malignancy. With these criteria, 47 more cases 
were excluded with 214 cases forming the study population.
Socio -demographic characteristics, obstetric and 
gynecological history, perioperative and postoperative 
characteristics were recorded in a proforma. Uterine size 
was determined by clinical assessment using comparison to 
equivalent gestational age in weeks. Fibroids were classified 
by pelvic ultrasound into subserous, submucous, intramural, 
or multiple (>1) types.
Each surgery was done by either a consultant or senior 
resident (PGY 4 or higher) as a lead surgeon. A Foley’s catheter 
was used as a tourniquet at the cervical-isthmic junction for 
hemostasis during all myomectomies, chemical hemostasis 
was not utilized. Estimation of blood loss was done by the 
anesthetist, the total amount from the suction bottle, pieces 
of gauze, abdominal packs, and blood lost in the drapes was 
used to calculate the intraoperative blood loss.
Morbidity was defined as any alteration in normal 
physiological function due to the surgery. Hemorrhage was 
defined as blood loss >1000 ml at surgery and pyrexia was a 
temperature in first 72 hours of >37.5°C. Data was collated 
and entered into a datasheet using SPSS v. 14.0 (Chicago, 
Illinois). Frequency tables and the Chi-square test were used 
for categorical data and continuous variables were analyzed 
using the independent t-test. Significant P value was <0.05.
Results
The mean age of the population was 38.3 ± 6.9 years (range: 
26–61 years), majority of them were in the 37–47 years 
age group (62.1%). Table 1 compares socio-demographic 
and clinical variables in both groups. Age was the only 
significantly different variable—younger women were more 
likely to have myomectomies. Seventy-nine patients (36.9%) 
had hysterectomy (HST) and 135 women (63.1%) had 
myomectomy (MYO). The median uterine size was 18 weeks 
for the whole group. For MYO patients, the median 
uterine size preoperatively was 20 weeks (8–38 weeks) 
and the HST group had a preoperative median size of 
18 weeks (8–36 weeks).
Table 2 compares the sites of myomas in patients of either 
group, most fibroids were intramural. Table 3 compares 
preoperative, intraoperative, and postoperative characteristics 
in both groups. No intraoperative or postoperative mortality 
occurred. No significant differences were observed. The 
prevalence of complications was 22.7% (46 participants). 
Transfusion rates were 34.3% in the MYO group and 39.5% 
in the HST group (P = 0.31) (even though there were more 
patients transfused in the MYO than the HST group). The 
incidence of morbidities was also comparable between the 
two groups. Hemorrhage occurred in 77 (36.0%), wound 
infection in 10 (4.7%) and postoperative fever in 4 (1.9%). One 
patient in the HST group had vault cellulitis (0.5%). There was 
no conversion to hysterectomy in the myomectomy group. 
No significant difference was observed in the prevalence of 
complications in either surgery group.[Table 4].
Discussion
This study aimed to determine the prevalence of 
complications following surgical management of fibroid 
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uteri by myomectomy or hysterectomy. In our study, the 
only significant socio-demographic variable for was age. This 
highlighted the tendency towards uterine conservation in 
younger women. The spectrum of morbidities were similar to 
that found in previous research; hemorrhage, wound sepsis, 
and pyrexia.[9-12]
Abdominal myomectomy has been associated with a greater 
likelihood of morbidities, particularly fever,[13,14] partly 
explained by bleeds into the cavities left by enucleated 
fibroids. Apart from hemorrhage, morbidities were few in 
this series. There were no significant differences in the two 
groups; though, the small sample size may be a contributory 
factor.
Our study has re-emphasized the need to prepare for and 
prevent occurrence of hemorrhage during fibroid surgery. 
This commences from the preoperative work up, ensuring 
blood and blood products are made available, and the use of 
hemostatic techniques. In our study, the only intraoperative 
method used to aid hemostasis for myomectomy was 
mechanical, the Foley’s catheter. The importance of ensuring 
meticulous surgical technique in securing vascular pedicles 
during hysterectomy and closure of cavities following 
enucleation of fibroid nodules cannot be overstated. Studies 
have also highlighted the availability of pharmacological 
or chemical methods for control of hemorrhage during 
myomectomy.[13,14]
In conclusion, there may not be any significant difference in 
the incidence and types of morbidities following abdominal 
myomectomy or hysterectomy for uterine fibroids. 
Gynecologists should ensure adequate preparations to 
control blood loss before and during fibroid surgery. The 
efficacy of hemostatic agents during myomectomy in our 
environment may also require further study.
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